Contineum Therapeutics, Inc. Class A Common Stock Free Cash Flow Generation Index
Contineum Therapeutics, Inc. Class A Common Stock free cash flow generation index. Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a Free Cash Flow Generation Index of 1.00x as of June 2023. Free cash flow of $40.64 Million represents 1% of operating cash flow ($40.67 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Contineum Therapeutics, Inc. Class A Common Stock (2023–2023)
Free cash flow generation index of Contineum Therapeutics, Inc. Class A Common Stock from 2023 to 2023. Historical FCF Generation Index trend for Contineum Therapeutics, Inc. Class A Common Stock across 1 annual periods. See financial flexibility index of Contineum Therapeutics, Inc. Class A Com to measure the company's free cash flow as a share of total liabilities.
Contineum Therapeutics, Inc. Class A Common Stock Free Cash Flow Generation Index by Year (2023–2023)
Contineum Therapeutics, Inc. Class A Common Stock free cash flow generation index by year from 2023 to 2023. Year-by-year Free Cash Flow Generation Index for Contineum Therapeutics, Inc. Class A Common Stock. For the full cash flow conversion analysis, see CTNM cash generation efficiency.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.98x | $18.93 Million | $19.35 Million | $414.00K | — |